MorphoSys (NASDAQ:MOR – Get Free Report)‘s stock had its “market perform” rating reissued by analysts at Leerink Partnrs in a research note issued to investors on Wednesday, PriceTargets.com reports. Leerink Partnrs also issued estimates for MorphoSys’ FY2026 earnings at ($0.78) EPS. A number of other equities research analysts have also weighed in on the stock. […]